Molbio Diagnostics IPO
Latest news, explainers and analysis on Molbio Diagnostics IPO. Tracking 2 stories on Arth Vani.
Connected in the graph
Latest on Molbio Diagnostics IPO
IPOBreakingMolbio Diagnostics IPO Allotment Today: Check Status as GMP Signals Strong Listing
The allotment for Molbio Diagnostics IPO is set for finalization today, August 13, following a massive 70.26x subscription. Investors can check their status online as the grey market premium suggests a positive debut on the stock exchanges.
IPOBreakingMolbio Diagnostics IPO Opens Today: Analysts See Value, GMP at 15%
The Initial Public Offering (IPO) for Molbio Diagnostics opened today, with market analysts recommending subscription. The company's valuations are noted to be in line with industry benchmarks and offered at a discount to its listed peers' average P/E multiple of 64.9x. The Grey Market Premium (GMP) for the issue is reported at 15%.
IPO investments are subject to market risk and allotment. Read the RHP / prospectus before applying; grey-market premium (GMP) is unofficial and unreliable. Some listings may be sponsored. Not investment advice.